Isabel Nees
Physician Assistant · Fairfield, CTNPI 1215622774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $991 and has fallen 81.7% since, to $181 in 2025.
Across 64 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$196
- AbbVie$194
- Exact Sciences$153
- Shield Therapeutics Inc$90
- Astellas Pharma US Inc$86
- AstraZeneca$81
- plus $470 from 15 others
What the payments were for
- Food & beverage$1,269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $196 |
| AbbVie | 9 | $194 |
| Exact Sciences | 7 | $153 |
| Shield Therapeutics Inc | 4 | $90 |
| Astellas Pharma US Inc | 4 | $86 |
| AstraZeneca | 5 | $81 |
| Lilly USA, LLC | 4 | $74 |
| GSK | 4 | $61 |
| Merck | 3 | $55 |
| Pfizer | 2 | $40 |
| Dexcom, Inc. | 1 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $34 |
| Tris Pharma Inc | 1 | $24 |
| Amgen | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Bayer | 1 | $22 |
| Corium, LLC | 1 | $20 |
| Almatica Pharma LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
How this compares
$1,269 in reported general payments places this provider in the 80th percentile of 1,795 physician assistant providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 16 | $21,902 |
| MounjaroTirzepatide | 12 | $12,906 |
| FarxigaDapagliflozin Propanediol | 13 | $11,867 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,523 |
| ValacyclovirValacyclovir Hcl | 15 | $1,081 |
| Atorvastatin Calcium | 103 | $789 |
| Levothyroxine Sodium | 63 | $747 |
| Tamsulosin Hcl | 20 | $658 |
| Metformin Hcl ErMetformin Hcl | 20 | $422 |
| Lisinopril | 63 | $295 |
| Metformin Hcl | 43 | $290 |
| Losartan Potassium | 31 | $278 |
| Rosuvastatin Calcium | 21 | $264 |
| Cyclobenzaprine Hcl | 19 | $246 |
| Omeprazole | 13 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $196 | $21,90216 claims |
| Lilly USA, LLCMounjaro | $74 | $12,90612 claims |
| AstraZenecaFarxiga | $81 | $11,86713 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $5013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in Fairfield
- Marina MathewFairfield$20K
- Brian ClancyFairfield$17K
- Emily RomanFairfield$13K
- Emily KnowltonFairfield$10K
- Imran MridhaFairfield$9K
- Gary SpinnerBridgeport$119K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.